OBJECTIVES: Cerebrovascular events (CVE) cause major health problems and significant financial burden. Concomitant malnutrition may deteriorate prognosis of CVE and increase management costs. The study aims to describe daily practice for CVE management in patients with/without malnutrition in terms of diagnosis, treatment and follow-up. In this abstract, we calculate direct medical costs related to CVE in patients with/without malnutrition from the perspective of the local reimbursement authority in Turkey (SSI). METHODS: Acute CVE patients are generally referred to tertiary centers in Turkey, therefore neurology specialists experienced on CVE management from 8 tertiary-centers filled out a questionnaire including questions about diagnosis, treatment and follow-up of CVE. Answers were combined and summarized by using mean and standard error(SE). Direct medical costs were calculated by using package price and drug price lists of SSI in December 2013. Time horizon of analysis was 1 year. Monetary results were converted by using 2.1 USD/TL exchange rate. RESULTS: Mean(SE) 76.4(7.5)% of patients were hospitalized at first admittance (mean(SE) 39.2(7.7)% were to intensive-care unit). Mean(SE) mortality rate of the first admittance was 10.3(2.9)%. The first admittance of patients with/without malnutrition cost mean(SE) $3062(513) and $1958(372), respectively. During 1-year follow-up period; mean(SE) 93.8(15.4)% and 43.3(3.7)% of patients with/without malnutrition were expected to experience at least 1 complication, respectively. Routine procedures and complications during 1-year follow-up cost mean(SE) $2140(390) and $1660(340) for patients with/without malnutrition, respectively. Overall mean(SE) 1-year cost of patient with/without malnutrition $5201(740) and $3618(614) respectively. Of total amounts, oral nutrition supplements (ONS) cost mean(SE) $868(335) and $501(281) whereas all others cost mean(SE) $4334(807) and $3117(636), respectively. CONCLUSIONS: The results of analysis revealed that management of CVE and its complications have a relatively high burden on the Turkish health reimbursement system. Moreover, malnutrition increases overall costs and, investment in ONS may decrease overall CVE management cost.